Alpek (MEX:ALPEKA) 5-Year EBITDA Growth Rate: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ALPEKA Alpek SA MEX:ALPEKA
63 GF Score
Price MXN12.55
GF Value MXN11.60
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Alpek 5-Year EBITDA Growth Rate?

Alpek MEX:ALPEKA +0.08% 63 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus rates MEX:ALPEKA with a GF Score™ of 63/100 and a GF Value™ of MXN11.60 (Fairly Valued). The stock has 8 warning signs investors should review.

Alpek's EBITDA per Share for the three months ended in Jun. 2026 was MXN3.63.

During the past 12 months, Alpek's average EBITDA Per Share Growth Rate was 6.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -36.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Alpek was 37.50% per year. The lowest was -36.40% per year. And the median was -0.20% per year.


Alpek  (MEX:ALPEKA) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Alpek 5-Year EBITDA Growth Rate Related Terms


MEX:ALPEKA vs LIN, SHW, ECL: 5-Year EBITDA Growth Rate Comparison

For the Specialty Chemicals subindustry, Alpek's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpek 5-Year EBITDA Growth Rate vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Alpek's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Alpek's 5-Year EBITDA Growth Rate falls into.


MEX:ALPEKA
63GF Score
Alpek SA MEX:ALPEKA
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpek 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
Alpek (MEX:ALPEKA) has a 5-Year EBITDA Growth Rate of 0.00% as of Jun. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Alpek and its competitors.
Is Alpek's 5-Year EBITDA Growth Rate too high?
Alpek's current 5-Year EBITDA Growth Rate is 0.00%. Overall, Alpek has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alpek's 5-Year EBITDA Growth Rate compare to LIN and SHW?
Alpek's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Chemicals company?
A good 5-Year EBITDA Growth Rate depends on the Chemicals industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Alpek and its competitors. Alpek's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpek stock overvalued right now?
Based on GuruFocus' analysis, Alpek (MEX:ALPEKA) is currently considered Fairly Valued. The stock's GF Value™ is MXN11.60, compared to a current price of MXN12.55 — trading 8.2% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 0.00%. Alpek's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Alpek (MEX:ALPEKA), the current 5-Year EBITDA Growth Rate is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alpek (MEX:ALPEKA) Overvalued in 2026?

Based on GuruFocus' analysis, Alpek stock appears to be overvalued. The current stock price of MXN12.55 is trading 8.2% above its estimated GF Value™ of MXN11.60. GuruFocus considers Alpek to be Fairly Valued.

Key valuation signals for MEX:ALPEKA:

  • 5-Year EBITDA Growth Rate: 0.00%
  • GF Value™: MXN11.60 vs. price of MXN12.55 (8.2% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the MEX:ALPEKA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alpek Business Description

Other Exchanges ALPKF:USA27A:Germany
Address Avenida Gomez Morin Sur No. 1111, Col. Carrizalejo, San Pedro Garza Garcia, NL, MEX, 66254
Alpek SA is a petrochemical company with operations through two business segments: Polyester and Plastic and Chemicals. The Polyester segment comprises the production of purified terephthalic acid (PTA), polyethylene terephthalate (PET), recycled PET (rPET), and polyester fibers, which are mainly used for food and beverage packaging, textile and industrial filament markets, and The Plastics & Chemicals business segment comprises the production of polypropylene (PP), expandable styrene (EPS and Arcel), fertilizers and other chemicals, which serves a wide range of markets, including the consumer goods, automotive, construction, agriculture, pharmaceutical, and other markets. The company derives a majority of its revenue from the polyester segment.
63GF Score

Get the complete analysis for MEX:ALPEKA

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN12.55
Price
MXN11.60
GF Value